CLP 722.93
(0.41%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 105.54 Billion CLP | 21.67% |
2022 | 126.53 Billion CLP | 103.89% |
2021 | 70.03 Billion CLP | 45.32% |
2020 | 65.99 Billion CLP | -55.42% |
2019 | 61.89 Billion CLP | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 21.75 Billion CLP | -15.16% |
2024 Q1 | 14.5 Billion CLP | -9.1% |
2023 Q4 | 29.39 Billion CLP | -1.09% |
2023 FY | - CLP | 21.67% |
2023 Q3 | 29.71 Billion CLP | 46.27% |
2023 Q2 | 20.31 Billion CLP | 1.42% |
2023 Q1 | 20.03 Billion CLP | -64.08% |
2022 Q3 | 30.88 Billion CLP | 0.0% |
2022 FY | - CLP | 103.89% |
2022 Q4 | 55.76 Billion CLP | 80.54% |
2021 FY | - CLP | 45.32% |
2020 FY | - CLP | -55.42% |
2019 FY | - CLP | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
SalfaCorp S.A. | 74.1 Billion CLP | -42.424% |